FEI Tribunal issues Consent Award in equine anti-doping case

Media updates
28 March 2024 Author: FEI

The FEI Tribunal has issued a Consent Award in an equine anti-doping case involving a Banned Substance.

In this case, the horse Quastina (FEI ID 107MC69/BRA), tested positive for the Banned Substance Stanozolol following samples taken at the CSI5*-W São Paulo SP (BRA), 22 - 27 August, 2023.

The athlete, Lucio Vinicius De Oliveira Osório (FEI ID 10080702/BRA), admitted the rule violation and accepted the consequences. In its final decision the FEI Tribunal disqualified the horse from the event and imposed an 18-month ineligibility period on the athlete; the provisional suspension he already served shall be credited against the imposed ineligibility period. The athlete was also fined CHF 1,500.

The full Decision is available here.

Notes to Editors:

FEI Equine Prohibited Substances

The FEI Prohibited Substances List is divided into two sections: Controlled Medication and *Banned Substances. Controlled Medication substances are medications that are regularly used to treat horses, but which must have been cleared from the horse’s system by the time of competition. Banned (doping) Substances should never be found in the body of the horse and are prohibited at all times.

In the case of an adverse analytical finding (AAF) for a Banned Substance, the Person Responsible (PR) is automatically provisionally suspended from the date of notification (with the exception of certain cases involving a Prohibited Substance which is also a **Specified Substance). The horse is provisionally suspended for two months.

Information on all substances is available on the searchable FEI Equine Prohibited Substances Database.